Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The "Battery Electric Vehicle Market Size, Share & Trends Analysis Report by Vehicle Type, Vehicle Speed, Vehicle Range, Battery Capacity, End Use,...
-
Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The "5G in Agriculture Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The 5G in agriculture market has witnessed...
-
Woodward Publishes Its 2025 Sustainability Report Highlighting Progress in Environmental Stewardship, Social Responsibility, and Governance
-
Verde and Ergon Forge Commercial Collaboration to Build Roads of the Future with Engineered Biochar
-
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- The American Kennel Club (AKC®), a not-for-profit organization that is the world’s largest registry of purebred and mixed-breed dogs, and a leading voice...
-
ENGLEWOOD, Colo., June 30, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP), a global specialty chemicals company, has published its 2025 Sustainability Report, highlighting measurable progress...
-
SAN RAMON, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, released today its 2025 Corporate Sustainability Report. The report...
-
Delray Beach, FL, June 30, 2026 (GLOBE NEWSWIRE) -- The global Gas Engine Market size is projected to reach USD 6.3 billion by 2029, from USD 5.1 billion in 2024, at a CAGR of 4.5% according to a...
-
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need...
-
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need...